Network Analysis of Intrinsic Functional Brain Connectivity in Alzheimer's Disease
Overview
Affiliations
Functional brain networks detected in task-free ("resting-state") functional magnetic resonance imaging (fMRI) have a small-world architecture that reflects a robust functional organization of the brain. Here, we examined whether this functional organization is disrupted in Alzheimer's disease (AD). Task-free fMRI data from 21 AD subjects and 18 age-matched controls were obtained. Wavelet analysis was applied to the fMRI data to compute frequency-dependent correlation matrices. Correlation matrices were thresholded to create 90-node undirected-graphs of functional brain networks. Small-world metrics (characteristic path length and clustering coefficient) were computed using graph analytical methods. In the low frequency interval 0.01 to 0.05 Hz, functional brain networks in controls showed small-world organization of brain activity, characterized by a high clustering coefficient and a low characteristic path length. In contrast, functional brain networks in AD showed loss of small-world properties, characterized by a significantly lower clustering coefficient (p<0.01), indicative of disrupted local connectivity. Clustering coefficients for the left and right hippocampus were significantly lower (p<0.01) in the AD group compared to the control group. Furthermore, the clustering coefficient distinguished AD participants from the controls with a sensitivity of 72% and specificity of 78%. Our study provides new evidence that there is disrupted organization of functional brain networks in AD. Small-world metrics can characterize the functional organization of the brain in AD, and our findings further suggest that these network measures may be useful as an imaging-based biomarker to distinguish AD from healthy aging.
Kang S, Li L, Shahdadian S, Wu A, Liu H Neurophotonics. 2025; 12(1):015011.
PMID: 40018415 PMC: 11866628. DOI: 10.1117/1.NPh.12.1.015011.
Non-invasive brain stimulation in cognitive sciences and Alzheimer's disease.
Carrarini C, Pappalettera C, Le Pera D, Rossini P Front Hum Neurosci. 2025; 18:1500502.
PMID: 39877800 PMC: 11772349. DOI: 10.3389/fnhum.2024.1500502.
Machine Learning Recognizes Stages of Parkinson's Disease Using Magnetic Resonance Imaging.
Chudzik A Sensors (Basel). 2025; 24(24.
PMID: 39771887 PMC: 11679256. DOI: 10.3390/s24248152.
Roy O, Moshfeghi Y, Ibanez A, Lopera F, Parra M, Smith K Netw Neurosci. 2024; 8(4):1467-1490.
PMID: 39735505 PMC: 11674931. DOI: 10.1162/netn_a_00411.
Gu Q, Wang L, King T, Chen H, Zhang L, Ni J Cancer Imaging. 2024; 24(1):158.
PMID: 39558401 PMC: 11572057. DOI: 10.1186/s40644-024-00797-2.